Live symbol workspace

S market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $13.92

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$13.22

Resistance

$14.62

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$13.92

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▲ 0.2 pts vs previous week

Avg confidence across 218 calls in the last 7 days

What sources say

Bearish 2 articles

S token drops 5% as 3 former execs resign from Sonic Labs board

Zoom, monday.com, and SentinelOne Shares Are Falling, What You Need To Know

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

S News Intelligence (2333 articles)

AI-curated news influencing S price, sentiment, and trend

Explore All S News with AI Analysis

Global Markets & Finance

7 months, 1 week ago

AI Caution, US Stocks Slip as Softbank Sells Nvidia Stake | The Pulse 11/11

"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, …

Impact on S: Market impact analysis based on bearish sentiment with 71% confidence.

US stocks slipped as Softbank sold its stake in Nvidia, raising concerns about AI market … High (71%)

View full analysis →

Bloomberg 71% confidence

Cryptocurrency

7 months, 1 week ago

Gemini bets on ‘super app’ as stock sinks to record low on Q3 results

Shares in Gemini slumped after the company reported losses in its third-quarter results, largely due to the costs associated with …

Impact on S: Market impact analysis based on bearish sentiment with 82% confidence.

Gemini's stock has plummeted to a record low following the company's Q3 results, which revealed … High (82%)

View full analysis →

Unknown 82% confidence

Economy

7 months, 1 week ago

Why Opendoor Technologies Stock Skyrocketed 21.5% Today

Opendoor investors are hoping more rate cuts are coming from the Federal Reserve.

Impact on S: Market impact analysis based on bullish sentiment with 65% confidence.

Opendoor Technologies stock surged 21.5% due to investors' optimism about potential future rate cuts from … Medium (65%)

View full analysis →

Unknown 65% confidence

Stocks

7 months, 1 week ago

How major US stock indexes fared Monday, 11/10/2025

Big Tech and other superstars of the U.S. stock market rallied, and Wall Street recovered most of its loss from …

Impact on S: Market impact analysis based on bullish sentiment with 79% confidence.

US stock indexes, including the Dow Jones and Nasdaq, experienced a significant recovery on Monday, … High (79%)

View full analysis →

Unknown 79% confidence

Stocks

7 months, 1 week ago

Stock Market Today: Nasdaq Jumps On Shutdown Hopes; This Stock Gets Support (Live Coverage)

The Dow Jones index was up on the stock market today as government shutdown hopes rose. Bitcoin rallied while Nvidia …

Impact on S: Market impact analysis based on bullish sentiment with 90% confidence.

The stock market experienced a positive day with the Dow Jones index rising due to … High (90%)

View full analysis →

Unknown 90% confidence

Stocks

7 months, 1 week ago

Cogent Biosciences Stock Surges 127%. Why Investors See Promise in Its Cancer Drug.

The biotech reported positive trial data for a treatment targeting patients with gastrointestinal stromal tumors.

Impact on S: Market impact analysis based on bullish sentiment with 90% confidence.

Cogent Biosciences' stock has surged 127% after reporting positive trial data for its cancer treatment … High (90%)

View full analysis →

Unknown 90% confidence